SEARCH

SEARCH BY CITATION

References

  • American Psychiatric Association. 1999. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156(5 Suppl): 120.
  • American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorder, Text Revision. 4th edition. American Psychiatric Press: Washington, DC.
  • Devlin JW, Roberts RJ, Fong JJ, et al. 2010. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 38: 419427.
  • Elie M, Boss K, Cole MG, et al. 2009. A retrospective, exploratory, secondary analysis of the association between antipsychotic use and mortality in elderly patients with delirium. Int Psychogeriatr 21: 588592.
  • Gardner DM, Murphy AL, O'Donnell H, et al. 2010. International consensus study of antipsychotic dosing. Am J Psychiatry 167: 686693.
  • Guy W. 1976. ECDEU assessment manual for psychopharmacology. US Dept of Health, Education, and Welfare: Bethesda.
  • Huybrechts KF, Gerhard T, Crystal S, et al. 2012. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ 344: e977.
  • Inada T. 1996. Evaluation and Diagnosis of Drug-induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to its Usage. Seiwa Shoten Publishers: Tokyo.
  • Knol W, van Marum RJ, Jansen PA, et al. 2008. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 56: 661666.
  • Lacasse H, Perreault MM, Williamson DR. 2006. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 40: 19661973.
  • Lonergan E, Britton AM, Luxenberg J, et al. 2007. Antipsychotics for delirium. Cochrane Database Syst Rev 2: CD005594.
  • Ma N, Liu WY, Li HD, et al. 2007. Determination of perospirone by liquid chromatography/electrospray mass spectrometry: application to a pharmacokinetic study in healthy Chinese volunteers. J Chromatogr B Analyt Technol Biomed Life Sci 847: 210216
  • Marder SR, McQuade RD, Stock E, et al. 2003. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 61: 123136.
  • Meagher D, Moran M, Raju B, et al. 2008. A new data-based motor subtype schema for delirium. J Neuropsychiatry Clin Neurosci 20: 185193.
  • Menza MA, Murray GB, Holmes VF, et al. 1987. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 48: 278280.
  • Michaud L, Büla C, Berney A, et al. 2007. Delirium: guidelines for general hospitals. J Psychosom Res 62: 371383.
  • Schneider LS, Dagerman KS, Insel P. 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294: 19341943.
  • Tahir TA, Eeles E, Karapareddy V, et al. 2010. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 69: 1485490.
  • Trzepacz PT. 1999. The delirium rating scale. Its use in consultation-liaison research. Psychosomatics 40:193204.
  • US Food and Drug Administration. 2005. FDA Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. [http://www.fda.gov/cder/drug/advisory/antipsychotics.htm]
  • Wang PS, Schneeweiss S, Avorn J, et al. 2005. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 353: 23352341.